GeneDx’s Post

Curious how to cut clonal cell population generation times to as little as ~3 weeks? Watch our free on-demand webinar "Improving Genome Editing Pipeline Efficiencies with Nanopipette Delivery": https://lnkd.in/gZy5QmZC #genomeediting #su10 #nanopipette #webinar #cellpopulation

Whole genome sequencing is currently the most comprehensive test available on the market, however, there are lots of factors that can influence a decision to perform genome sequencing. Learn more in this "Hot Topic." https://bit.ly/4aKjT6h

Whole genome sequencing and whole exome sequencing are powerful tools that can help uncover underlying #genetic conditions. Read our #whitepaper to learn more about these advanced tests and how careivso helps patients get access: https://ow.ly/m8ev50QChQk

CRISPR-Cas12a processes its guide RNA by tightly binding and cleaving it. This study shows how different regions of the RNA impact binding and suggests strategies for efficient genome editing.  https://bit.ly/4cfkcGn

This paper indicates the potential of ML- guided whole genome sequencing to guide the choice of phage for therapy. Phage-UK (www.phageuk.com) https://lnkd.in/ew7gDKKs

Did you know, that rare diseases impact 300 million people worldwide, yet receiving an accurate diagnosis remains challenging❓Dr. Ali M Tabish, PhD. from Geneyx wrote an article explaining "The Role of Whole Genome and Exome Sequencing in Uncovering Variants in Rare Diseases."  It is estimated that only 10% of rare diseases can be quickly diagnosed with standard clinical practices. The genetic origin behind rare diseases also makes them particularly difficult to identify and understand. Advancements in genomic technologies like 𝑮𝒆𝒏𝒆𝒚𝒙 𝑨𝒏𝒂𝒍𝒚𝒔𝒊𝒔 are dramatically improving our ability to achieve genetic diagnoses.  Read below Ali's recent article 👇 https://lnkd.in/dsacDm-X #raredisease #genetics #wholegenomesequencing #healthcare #clinicalresearch

In support of #rarediseaseday, Stephen Kingsmore willing posed with me in my zebra stripes at Rady Children's Institute for Genomic Medicine! Every single day Dr. Kingsmore and all my other colleagues work to make ultra-rapid whole genome sequencing testing available for every patient who might benefit. For us, it's our mission to try to take some of the burden off the moms and dads of those little kiddos who tenaciously strive to find answers and get help for their kids. I can't imagine what they go through. #raredisease #rarediseaseday #wholegenomesequencing #genetictesting #geneticdisease

Next-generation sequencing (NGS) is transforming genetic diagnostics, allowing millions of DNA bases to be analyzed quickly and efficiently. What are the advantages of NGS? - Faster speed: Get results in days instead of weeks. - Higher accuracy: Detects smaller and more complex genetic variants. - Lower cost: The price per sequenced base has decreased dramatically. - Increased capacity: Analyzes multiple genes or even the entire genome at once. NGS allows a more accurate diagnosis, identifying the genetic cause of rare and complex diseases. In addition, thanks to it, a more personalized approach can be offered, tailoring treatment to the individual characteristics of each patient. #NGS #sequencing #genetics #diagnosis #personalizedmedicine

To “Infinium” and beyond 😉 Learn why Illumina’s Infinium arrays are a powerful tool and a robust technology capable of generating comprehensive coverage of genetic variants, high-throughput genotyping whilst remaining cost-effective, and scalable. #GenomeEra #BuzzLightyear

With our whole genome platform we regularly solve cases where the diagnostic variant was missed by prior exome testing. Until now there’s been little formal data measuring the incremental benefit of genome sequencing. That’s changed with a recent study published in NEJM where the authors found a full 8% of diagnoses were possible only with genome sequencing. With such a significant gain genome sequencing is the clear choice. ➡️ https://lnkd.in/dStKj9qs